G.E.T. Issues Voluntary Recall of ArimaDex
Free ArimaDex Aromatase Inhibitor Recall Case Evaluation: If you or a loved one has experienced any adverse side effects after taking ArimaDex, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.
What’s the problem?
September 16, 2010 - Genetic Edge Technologies of Phoenix, Arizona is currently recalling 60 count bottles of ArimaDex because it may contain an Aromatase Inhibitor. ArimaDex was distributed throughout the United States to national sports supplements distributors and could be purchased by consumers via retail stores, mail order, and Internet sales. The drug comes in white bottles with orange labels containing 60 orange soft gels. Arimadex is sold with UPC Code 718122466511 appearing on the label. All lot numbers of ArimaDex are being affected by this voluntary recalled.
Adverse Events associated with ArimaDex
Genetic Edge Technologies has been informed by the US Food and Drug Administration (FDA) that potential adverse events associated with the use of Aromatase Inhibitors could include the following:
- decreased rate of bone maturation and growth
- decreased sperm production
- aggressive behavior
- adrenal insufficiency
- kidney failure
- liver dysfunction
Consumers with liver, kidney, adrenal, or prostate abnormalities are at a potentially higher risk for developing adverse events. The FDA concludes that products containing aromatase inhibitors have an increased probability of developing adverse reactions in at-risk consumers.
Do I have an ArimaDex Recall Lawsuit?
The Defective Drug & Products Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in ArimaDex Aromatase Inhibitor recall lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.